Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.
Globally, there is a low rate of guideline-consistent treatment of mental and substance use disorders, with wide individual and country variations.
Gastroesophageal symptoms significantly impact methotrexate dosages and disease activity among patients with RA.
A total of 62.7% of patients expressed the desire to be notified about the use of artificial intelligence (AI) in patient care.